Table 2.
Control group characteristics.
| Control group A (n = 41) | Control group B (n = 23) | |
|---|---|---|
| Age (years) | 28.6 ± 6.3 | 29.0 ± 5.7 |
| Female, n (%) | 18 (43.9) | 10 (43.5) |
| BMI (kg/m2) | 21.2 ± 1.7 | 22.1 ± 1.8 |
| Medical comorbidities | None | None |
| Laboratory measurements | ||
| Hb (g/dL) [normal: female ≥12/male ≥13] | 14.7 ± 0.7 | 13.9 ± 0.5 |
| TSAT (%) [normal: 20.0–45.0] | 32.7 ± 3.5 | 31.7 ± 2.7 |
| COVID-19-related characteristics | ||
| Prior COVID-19 infection (reported) | Yes | No |
| COVID-19 vaccination | No | Yesa |
| COVID-19 illness severity | ||
| Mild, n (%) | 41 (100) | – |
| Moderate, n (%) | 0 (0) | – |
| Severe, n (%) | 0 (0) | – |
| Critical, n (%) | 0 (0) | – |
| Death, n (%) | 0 (0) | – |
Data are presented as means ± SD or proportions n with corresponding percentages (%). For some variables, the [normal range] was added to the table.
Abbreviations: BMI, body mass index; COVID-19, coronavirus disease 2019; Hb, haemoglobin; TSAT, transferrin saturation.
a
Individuals were vaccinated with 2 doses of the Pfizer-BioNTech vaccine.